|
Dr. Pertschuk oversees the clinical development of Spectrum's portfolio of oncology-focused drugs. Dr Pertschuk reports directly to Dr. Luigi Lenaz, Chief Scientific Officer.
Dr. Pertschuk received his MD degree from the University of Pennsylvania and is Board Certified in Internal and Geriatric Medicine. During the past fifteen years, he has had increasing responsibilities in designing and implementing clinical development programs in a number of different therapeutic areas including oncology. Prior to joining Spectrum, Dr. Pertschuk was Executive Director of Clinical Development at CancerVax, where he was involved in the successful implementation of two large immunotherapy survival trials in patients with advanced melanoma. | 